Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Akero Therapeutics Inc (AKRO)

34.61   0.15 (0.44%) 08-13 16:00
Open: 34.04 Pre. Close: 34.46
High: 35.19 Low: 33.94
Volume: 246,839 Market Cap: 1,201M
Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Its lead product candidate is AKR-001, which is in Phase IIa clinical trial for the treatment of nonalcoholic steatohepatitis disease.The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 35.24 - 35.438 35.438 - 35.618
Low: 33.423 - 33.679 33.679 - 33.914
Close: 34.237 - 34.61 34.61 - 34.952

Technical analysis

as of: 2020-08-13 4:31:25 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 43.23     One year: 46.49
Support: Support1: 32.50    Support2: 27.04
Resistance: Resistance1: 37.01    Resistance2: 39.80
Pivot: 35.73
Moving Average: MA(5): 34.87     MA(20): 36.02
MA(100): 26.67     MA(250): 23.72
MACD: MACD(12,26): 0.57     Signal(9): 1.12
Stochastic oscillator: %K(14,3): 23.62     %D(3): 21.74
RSI: RSI(14): 49.52
52-week: High: 41.16  Low: 10.78  Change(%): 31.4
Average Vol(K): 3-Month: 37593  10-Days: 22214

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
AKRO has closed above bottom band by 17.9%. Bollinger Bands are 51.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to AKRO's normal range. The bands have been in this narrow range for 11 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 13 Aug 2020
H.C. Wainwright Stick to Their Buy Rating for Akero Therapeutics Inc -

Wed, 12 Aug 2020
Akero Therapeutics Reports Second Quarter 2020 Financial Results - PRNewswire

Mon, 10 Aug 2020
may delivered a positive earnings surprise Akero Therapeutics (NASDAQ:AKRO) - Stock Market Daily

Thu, 30 Jul 2020
How Much Of Akero Therapeutics, Inc. (NASDAQ:AKRO) Do Institutions Own? - Simply Wall St

Wed, 22 Jul 2020
Akero Therapeutics Inc. (AKRO): Choosing The Technical Investor Route - The Comet Reports

Tue, 21 Jul 2020
Research Published in Cell Reports Medicine Highlights Potential of Akero Therapeutics' NASH Therapeutic Candidate - PRNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 35
Shares Float (M) 14
% Held by Insiders 9.51
% Held by Institutions 84.23
Shares Short (K) 1,120
Shares Short P. Month (K) 569

Stock Financials

EPS -2.270
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 4.130
Profit Margin
Operating Margin
Return on Assets (ttm) -33.0
Return on Equity (ttm) -53.5
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -42
Levered Free Cash Flow (M) -24

Stock Valuations

PE Ratio -15.25
PEG Ratio
Price to Book value 8.38
Price to Sales
Price to Cash Flow -28.94

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.